N-(4-Amino-2-chloro-benzoyl)-4-chloro-benzenesulfonamide; Compound with Trifluoroacetic salt

ID: ALA1161726

PubChem CID: 46905535

Max Phase: Preclinical

Molecular Formula: C15H11Cl2F3N2O5S

Molecular Weight: 345.21

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc(C(=O)NS(=O)(=O)c2ccc(Cl)cc2)c(Cl)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C13H10Cl2N2O3S.C2HF3O2/c14-8-1-4-10(5-2-8)21(19,20)17-13(18)11-6-3-9(16)7-12(11)15;3-2(4,5)1(6)7/h1-7H,16H2,(H,17,18);(H,6,7)

Standard InChI Key:  GXSNJRJFQMCFOY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 28  0  0  0  0  0  0  0  0999 V2000
    5.2792   -0.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2792    0.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5667    0.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9917    0.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4542   -0.7625    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    6.1042   -0.7625    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.2792   -1.5875    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5458    0.0833    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8250   -0.3250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1125    0.0833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3958   -0.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3167    0.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2625    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1250    0.8000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9625   -0.6375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3958   -1.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0375   -0.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1083    0.9208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2625    1.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9833    0.0833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0375   -1.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3167    0.9000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.3167   -1.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6958    1.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542   -1.5792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6958    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9750    1.7458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4208    1.7500    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  2  2  0
  5  1  1  0
  6  1  1  0
  7  1  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 12 11  1  0
 13  8  1  0
 14  8  2  0
 15  8  2  0
 16 11  2  0
 17 12  2  0
 18 10  2  0
 19 13  2  0
 20 13  1  0
 21 17  1  0
 22 12  1  0
 23 16  1  0
 24 27  2  0
 25 21  1  0
 26 20  2  0
 27 19  1  0
 28 24  1  0
 26 24  1  0
 23 21  2  0
M  END

Associated Targets(Human)

FLT1 Tclin Vascular endothelial growth factor receptor (287 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 345.21Molecular Weight (Monoisotopic): 343.9789AlogP: 2.69#Rotatable Bonds: 3
Polar Surface Area: 89.26Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.29CX Basic pKa: 2.19CX LogP: 2.60CX LogD: 1.86
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.84Np Likeness Score: -1.50

References

1. Lobb KL, Hipskind PA, Aikins JA, Alvarez E, Cheung YY, Considine EL, De Dios A, Durst GL, Ferritto R, Grossman CS, Giera DD, Hollister BA, Huang Z, Iversen PW, Law KL, Li T, Lin HS, Lopez B, Lopez JE, Cabrejas LM, McCann DJ, Molero V, Reilly JE, Richett ME, Shih C, Teicher B, Wikel JH, White WT, Mader MM..  (2004)  Acyl sulfonamide anti-proliferatives: benzene substituent structure-activity relationships for a novel class of antitumor agents.,  47  (22): [PMID:15481975] [10.1021/jm030594r]

Source